logo
Select company
Select metric
$ 0Net Cash Flow - Financing
VS
Market
47
Sector
71
Industry
84
History
67
$ 12.66Close
$ 2.22 - $ 17.92 52-Week Range
Ticker Information

Ticker

GLTO

Company Name

GALECTO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GALECTO INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GLTO - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 171K
3/31/2024$ 2.85M
12/31/2023$ 2.88M
9/30/2023$ 2.94M
6/30/2023$ 3.19M
3/31/2023$ 530K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GALECTO INC's latest trailing twelve months (TTM) CF - Financing stands at $ 187.39M.
  • Over the past 5 years, GALECTO INC's average CF - Financing has been $ 24.47M.
  • The median CF - Financing for GALECTO INC during this period was $ 474.5K
  • GALECTO INC reached its highest CF - Financing over the past 5 years at $ 187.39M.
  • The lowest CF - Financing recorded by GALECTO INC in the same timeframe $ 0

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

GLTO - Net Cash Flow - Financing, Last 5 years

$ 0

Minimum

Dec 31, 2021

$ 187.39M

Maximum

Dec 31, 2020

$ 24.47M

Average

$ 474.5K

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.27M